Skip to main content
HOMEUNLISTED SHARESIPO CALENDARROAD TO IPOBLOGSPARTNER WITH US
MORE TO EXPLORE
OPEN DEMAT
ENQUIRE NOW
‹ ALL UNLISTED SHARES
Royalcare Super Speciality Hospitals logo
UNLISTED COMPANY PROFILE

ROYALCARE SUPER SPECIALITY HOSPITALS

HEALTHCARE LINE
INDICATIVE PRICE / SHARE
₹155
▲ +2.0% · 30-DAY
OTC REFERENCE PRICE · NOT AN OFFER TO DEAL
PRICE AS OF 02 SEPT 2026
VIEW DATA METHOD →
REQUEST CURRENT DETAILS →
INDICATIVE PRICE HISTORY · DATED OBSERVATIONS SINCE 2025

PRICE HISTORY.

Use the left and right arrow keys to inspect dated observations. Home selects the first observation and End selects the latest.

₹160
₹142
27 Nov 2520 Jul 2602 Sept 26

ALL-TIME LOW
₹142
ALL-TIME HIGH
₹160
WINDOW
ALL
NOT A STOCK-EXCHANGE QUOTE · NOT AN OFFER TO DEAL
THE TIMETABLE · KEY NUMBERS

Key numbers

Published fundamentals and the date each figure was recorded.

CALCULATION METHOD →
Market cap
₹2,924 Cr
Indicative price × reported outstanding shares
Min. investment
₹10,075
Indicative price × lot size
Lot size
65
P/E ratio
184.52
P/B ratio
9.20
EPS
0.84
ROE
5.87%
Book value
₹16.84
Face value
₹10
Debt / equity
1.34
THE BUSINESS · HOW IT EARNS

Royalcare Super Speciality Hospital Limited operates a multi-super-speciality hospital in Coimbatore. The company was incorporated in 2012 and its annual report says it commenced hospital operations in 2016 with this flagship facility. Its revenue comes from patient care and related healthcare activity, specifically in-patient services, out-patient services, pharmacy sales and dietary sales. The hospital also receives revenue for services rendered to patients who have not yet been discharged, recorded as unbilled revenue under its accounting policy. The business purchases consumables, hospital stores and medical equipment, and uses related-party equipment leases where applicable. The annual report describes NABH, JCI, SRC and CARF accreditations for its multi-speciality hospital and records continued investment in medical equipment. The operating model is therefore an integrated hospital-provider model: clinical services are delivered through the hospital, with pharmacy and dietary products supporting patient care, and revenue recognised from healthcare services and supporting sales.

About this company

Royalcare Super Speciality Hospital Limited is a Coimbatore-based healthcare company that owns and operates a large multi-disciplinary tertiary care hospital in Tamil Nadu. Incorporated in 2012, the company began clinical operations in 2015 and has since scaled into one of the region's prominent ultramodern hospital facilities, with bed capacity that has grown into the several-hundred-bed range as the institution expanded its infrastructure and service lines. The hospital provides care across a broad spread of medical and surgical specialities, including cardiology and cardiothoracic surgery, neurology and neurosurgery, orthopaedics, oncology, nephrology and urology, gastroenterology, and pulmonology, alongside critical care, emergency services, and allied diagnostic departments. This integrated, multi-speciality model positions Royalcare as a referral destination for complex and high-acuity treatment in and around the Coimbatore region of western Tamil Nadu, an area with a sizeable catchment population and growing demand for organised private healthcare. In terms of scale, the company reported revenue of around ₹338 crore for the financial year ended March 2024, supported by steady top-line growth and improving operating profitability over recent years. It has an authorised capital that supports a paid-up equity base of roughly ₹205 crore, with shares carrying a face value of ₹10 each. Registrar and transfer functions are handled by an established RTA, and the shares are admitted in dematerialised form with both depositories, which facilitates off-market transfers. Royalcare draws attention in the unlisted market because it represents a focused, single-asset hospital operator in the structurally expanding Indian private healthcare sector, a theme that has attracted investor interest as several listed hospital chains have demonstrated the long-duration nature of the business. As a public limited company that is not currently listed on the NSE or BSE and has not filed a draft prospectus, its equity changes hands through over-the-counter unlisted-share transactions, where prices are indicative and set by buyer-seller negotiation rather than an exchange order book. The combination of a recognisable regional brand, diversified speciality mix, and pre-listing status keeps it on the radar of participants who track healthcare-sector unlisted opportunities.

COMPANY AT A GLANCE
Sector lineHealthcare
SettlementNSDL / CDSL
Incorporated2012
Listing statusUnlisted / Pre-IPO
*INDICATIVE · TIMELINE MAY CHANGE · NOTHING FINAL UNTIL THE RHP

COMPANY REGISTRY · ON FILE

PUBLIC OR ADMIN-SUPPLIED DATA · VERIFY INDEPENDENTLY
CIN
U85100TZ2012PLC018984
PAN
AAGCR1968R
Incorporated
2012
Outstanding shares
18,86,58,478
Registered office
Door No. 1/520, Neelambur, Sulur Taluk, Coimbatore 641062, Tamil Nadu, India
GET COMPANY UPDATES
Leave your email — our desk keeps you posted on this company.
THE LOGBOOK · FINANCIALS BY YEAR

WHAT THE ENGINE HAS DONE.

AMOUNT UNIT NOT VERIFIEDFY22FY23FY24FY25
REVENUE30,10030,50033,27335,257
PAT2,1001,6002,4481,505
EPS (₹)1111
PAT MARGIN7%5%7%4%
CAUTION · AMOUNT UNIT AND FIELD-LEVEL SOURCES HAVE NOT BEEN VERIFIED · DO NOT RELY ON THESE FIGURES WITHOUT CHECKING THE COMPANY FILING

THE CREW · BOARD & MANAGEMENT

Dr. K. Madeswaran
Chairman cum Managing Director
Sri. T. Balachander
Director - Finance (CFO)
Dr. K. Chockalingam
Director
Cs. K. Rangasamy
Company Secretary
Sri. K. P. Alagesan
Director
Dr. Minu Madeswaran
Director
Dr. S. P. Thiruppathy
Independent Director
Sri. K. Muthusamy
Independent Director
COMPANY TIMELINE · EVENTS
13th Annual General Meeting scheduled (27 Sep 2025)
READ THE NOTICE →
THE GLOVEBOX · ANNUAL REPORTS
ENQUIRE NOW →
NON-BINDING · NO PAYMENT · NOT AN OFFER TO DEAL
RESEARCH DESK · QUESTIONS

COMMON QUESTIONS.

Is Royalcare Super Speciality Hospitals listed on the stock exchange?+

No. As of 2 September 2026, Royalcare Super Speciality Hospitals is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.

What is the Royalcare Super Speciality Hospitals unlisted share price?+

As of 2 September 2026, the indicative unlisted share price of Royalcare Super Speciality Hospitals is ₹155 per share. This is an over-the-counter reference price, not a stock-exchange quote.

What indicative minimum amount is displayed for Royalcare Super Speciality Hospitals unlisted shares?+

The displayed unit count is 65 share(s); at the indicative price of about ₹155, the displayed amount is approximately ₹10,075. This is a display convention, not evidence of inventory, an order minimum or a quote.

Is trading in Royalcare Super Speciality Hospitals unlisted shares legal in India?+

Unlisted shares can be transferred off-market in India, but the legal, tax and compliance position depends on the security, parties, documents and current rules. Verify the intermediary, issuer restrictions and applicable requirements before proceeding.

Is there a lock-in period for unlisted shares?+

A post-listing lock-in may apply under the rules in force at the time. The period and any exemptions can depend on the holder and acquisition, so check the current regulation and the issuer's offer documents rather than relying on a generic period.

Do you guarantee returns?+

No. Unlisted shares carry higher risk and lower liquidity than listed shares. Returns depend on company performance, market conditions and future listing outcomes. This is information only, not investment advice.

SIMILAR COMPANY PROFILES
HEALTHCARE LINE.
Prices shown are indicative over-the-counter reference prices, not an offer to deal. This page is information only and not investment advice. Unlisted shares carry higher risk and lower liquidity than listed shares. Settlement to your own demat account via NSDL / CDSL through registered intermediaries.
© 2026 BUYUNLISTEDSHARES · A BRAND OF GAYATRI FINANCIAL SYNERGY · SINCE 2002 · ‹ BACK TO HOME
TODAY'S INDICATIVE PRICES — PARAG PARIKH FINANCIAL ADVISORY SERVICES LIMITED ₹20,400 · CAPGEMINI TECHNOLOGY SERVICES INDIA LIMITED ₹10,400 · HDFC SECURITIES LIMITED ₹7,990 · NATIONAL STOCK EXCHANGE (NSE) ₹1,985 · BOAT (IMAGINE MARKETING LIMITED) ₹895 · CHENNAI SUPER KINGS (CSK) ₹249 · BIRA 91 (B9 BEVERAGES LIMITED) ₹82 · ZEPTO ₹33 · ORAVEL STAYS (OYO ROOMS) ₹24.5 · HUTTI GOLD MINES COMPANY LIMITED ₹1,19,838 — INDICATIVE, NOT AN OFFER TO DEAL —TODAY'S INDICATIVE PRICES — PARAG PARIKH FINANCIAL ADVISORY SERVICES LIMITED ₹20,400 · CAPGEMINI TECHNOLOGY SERVICES INDIA LIMITED ₹10,400 · HDFC SECURITIES LIMITED ₹7,990 · NATIONAL STOCK EXCHANGE (NSE) ₹1,985 · BOAT (IMAGINE MARKETING LIMITED) ₹895 · CHENNAI SUPER KINGS (CSK) ₹249 · BIRA 91 (B9 BEVERAGES LIMITED) ₹82 · ZEPTO ₹33 · ORAVEL STAYS (OYO ROOMS) ₹24.5 · HUTTI GOLD MINES COMPANY LIMITED ₹1,19,838 — INDICATIVE, NOT AN OFFER TO DEAL —